Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking

被引:49
作者
Kawaguchi, Y
Ito, A
Appella, E
Yao, TP
机构
[1] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA
[2] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.M505772200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The basal level of the tumor suppressor p53 is regulated by MDM2-mediated ubiquitination at specific lysines, which leads to p53 nuclear export and degradation. Upon p53 activation, however, these lysines become acetylated by p300/CREB-binding protein. Here we have reported an unexpected finding that p300-mediated acetylation also regulates p53 subcellular localization and can promote cytoplasmic localization of p53. This activity is independent of MDM2 but requires a p53 nuclear export signal and acetylation of multiple lysines by p300. Mechanistically, we showed that conversion of a minimal four of these lysines to alanines but not arginines mimics p300-mediated p53 nuclear export, and these lysine-neutralizing mutations effectively prevent p53 tetramerization, thus exposing the oligomerization-regulated nuclear export signal. Our study suggested a threshold mechanism whereby the degree of acetylation regulates p53 nucleus-cytoplasm trafficking by neutralizing a lysine-dependent charge patch, which in turn, controls oligomerization-dependent p53 nuclear export.
引用
收藏
页码:1394 / 1400
页数:7
相关论文
共 23 条
[21]   A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking [J].
Stommel, JM ;
Marchenko, ND ;
Jimenez, GS ;
Moll, UM ;
Hope, TJ ;
Wahl, GM .
EMBO JOURNAL, 1999, 18 (06) :1660-1672
[22]   Regulating the p53 system through ubiquitination [J].
Yang, YL ;
Li, CCH ;
Weissman, AM .
ONCOGENE, 2004, 23 (11) :2096-2106
[23]   Trichostatin and leptomycin - Inhibition of histone deacetylation and signal-dependent nuclear export [J].
Yoshida, M ;
Horinouchi, S .
ANTICANCER MOLECULES: STRUCTURE, FUNCTION, AND DESIGN, 1999, 886 :23-36